{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:14:05Z","timestamp":1791378845802,"version":"4.3.2"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13312-026-00366-9","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:14:19Z","timestamp":1784790859000},"page":"612-637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis and Management of Transfusion-Dependent Thalassemia: Evidence-Based Guidelines From the Pediatric Hematology Oncology Chapter of the Indian Academy of Pediatrics"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-5641","authenticated-orcid":false,"given":"Nita","family":"Radhakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyam","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulika","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Trehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobha","family":"Tuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revathi","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Colah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hem Chand","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Parakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Gomber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv Kumar","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine A.","family":"Rahiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Dalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Kartik","family":"Ganga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavin","family":"Jankharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirisha Rani","family":"Siddaiahgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashima","family":"Dabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet R.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avantika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purva","family":"Kanvinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. T. K.","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyendra","family":"Katewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranoti","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine Kaur","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhulika","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Sud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineeta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Prakash","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upendra","family":"Kinjawadekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchira","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Manglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"366_CR1","unstructured":"Indian Academy of Pediatrics, Pediatric Hematology Oncology Chapter. IAP-PHO Thalassemia Guidelines 2023 [Internet]. New Delhi: Indian Academy of Pediatrics; 2025 Accessed on Jan 30, 2026. Available from: https:\/\/www.phoindia.org\/images\/pdf\/2025\/IAP_PHO_Thalassemia_Guidelines.pdf."},{"key":"366_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1586\/ehm.09.74","volume":"3","author":"R Colah","year":"2010","unstructured":"Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of \u03b2-thalassemias and hemoglobin E disorders. Expert Rev Hematol. 2010;3:103\u201317.","journal-title":"Expert Rev Hematol"},{"key":"366_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/03630269.2021.2001346","volume":"46","author":"SS Yadav","year":"2022","unstructured":"Yadav SS, Panchal P, Menon KC. Prevalence and management of \u03b2-thalassemia in India. Hemoglobin. 2022;46:27\u201332.","journal-title":"Hemoglobin"},{"key":"366_CR4","unstructured":"Indian Council of Medical Research. National Rare Diseases Registry of India (NRROID) [Internet]. New Delhi: ICMR. Accessed on March 31, 2026. Available from: https:\/\/rdrdb.icmr.org.in\/registry\/."},{"key":"366_CR5","unstructured":"Ministry of Health and Family Welfare, Government of India. National Sickle Cell Anaemia Elimination Mission portal [Internet]. New Delhi: MoHFW. Accessed on March 31, 2026. Available from https:\/\/sickle.nhm.gov.in\/home\/guest_dashboard."},{"key":"366_CR6","volume-title":"Guidelines for the management of transfusion-dependent \u03b2-thalassaemia (TDT)","year":"2025","unstructured":"Taher AT, Farmakis D, Porter JB, Cappellini MD, Musallam KM, editors. Guidelines for the management of transfusion-dependent \u03b2-thalassaemia (TDT). 5th ed. Nicosia, Cyprus: Thalassaemia International Federation; 2025.","edition":"5th ed"},{"key":"366_CR7","unstructured":"Oxford Centre for Evidence Based Medicine. OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Accessed July 10, 2025. Available from: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence."},{"key":"366_CR8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-067836","volume":"155","author":"AH Matheny Antommaria","year":"2025","unstructured":"Matheny Antommaria AH, Kelleher M, Peterson RJ. Quality of evidence and strength of recommendations in American Academy of Pediatrics\u2019 guidelines. Pediatrics. 2025;155:e2024067836.","journal-title":"Pediatrics"},{"key":"366_CR9","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2017.018","volume":"9","author":"V De Sanctis","year":"2017","unstructured":"De Sanctis V, Kattamis C, Canatan D, et al. \u03b2-Thalassemia distribution in the old world: an ancient disease seen from a historical standpoint. Mediterr J Hematol Infect Dis. 2017;9:e2017018.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"366_CR10","doi-asserted-by":"publisher","DOI":"10.4081\/thal.2014.1955","volume":"4","author":"RB Colah","year":"2014","unstructured":"Colah RB, Gorakshakar AC. Control of thalassemia in India. Thal Rep. 2014;4:1955.","journal-title":"Thal Rep"},{"key":"366_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.hoc.2017.11.006","volume":"32","author":"V Viprakasit","year":"2018","unstructured":"Viprakasit V, Ekwattanakit S. Clinical classification, screening and diagnosis for thalassemia. Hematol Oncol Clin North Am. 2018;32:193\u2013211.","journal-title":"Hematol Oncol Clin North Am"},{"key":"366_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.hoc.2022.12.001","volume":"37","author":"N Tesio","year":"2023","unstructured":"Tesio N, Bauer DE. Molecular basis and genetic modifiers of thalassemia. Hematol Oncol Clin North Am. 2023;37:273\u201399.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 1","key":"366_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/ijlh.12527","volume":"38","author":"V Brancaleoni","year":"2016","unstructured":"Brancaleoni V, Di Pierro E, Motta I, Cappellini MD. Laboratory diagnosis of thalassemia. Int J Lab Hematol. 2016;38(Suppl 1):32\u201340.","journal-title":"Int J Lab Hematol"},{"key":"366_CR14","doi-asserted-by":"publisher","unstructured":"Weatherall DJ, Clegg JB (Eds). The Thalassaemia Syndromes [Internet]. Oxford, UK: Blackwell Science Ltd; 2001. Accessed on July 5, 2025. Available from: http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1002\/9780470696705.","DOI":"10.1002\/9780470696705"},{"key":"366_CR15","doi-asserted-by":"publisher","first-page":"E54","DOI":"10.1002\/ajh.26056","volume":"96","author":"KM Musallam","year":"2021","unstructured":"Musallam KM, Cappellini MD, Viprakasit V, Kattamis A, Rivella S, Taher AT. Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later. Am J Hematol. 2021;96:E54\u20136.","journal-title":"Am J Hematol"},{"key":"366_CR16","volume-title":"National standards for blood centres and blood transfusion services","author":"National Blood Transfusion Council, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India","year":"2022","unstructured":"National Blood Transfusion Council, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. National standards for blood centres and blood transfusion services. 2nd ed. New Delhi: MoHFW; 2022.","edition":"2nd ed"},{"key":"366_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/vox.13296","volume":"117","author":"S Shastry","year":"2022","unstructured":"Shastry S, Chenna D, Basavarajegowda A, Das S, Chaudhary RK. Red blood cell alloimmunization among recipients of blood transfusion in India: a systematic review and meta-analysis. Vox Sang. 2022;117:1057\u201369.","journal-title":"Vox Sang"},{"key":"366_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100588","volume":"37","author":"FT Shah","year":"2019","unstructured":"Shah FT, Sayani F, Trompeter S, Drasar E, Piga A. Challenges of blood transfusions in \u03b2-thalassemia. Blood Rev. 2019;37:100588.","journal-title":"Blood Rev"},{"key":"366_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ajts.AJTS_5_18","volume":"12","author":"A Bisht","year":"2018","unstructured":"Bisht A, Marwaha N, Kaur R, Gupta D, Singh S. Haemovigilance programme of India: analysis of transfusion reactions reported from January 2013 to April 2016 and key recommendations for blood safety. Asian J Transfus Sci. 2018;12:1\u20137.","journal-title":"Asian J Transfus Sci"},{"key":"366_CR20","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1182\/blood-2012-05-370098","volume":"120","author":"AV Hoffbrand","year":"2012","unstructured":"Hoffbrand AV, Taher A, Cappellini MD. How I treat transfusional iron overload. Blood. 2012;120:3657\u201369.","journal-title":"Blood"},{"key":"366_CR21","first-page":"489","volume":"88","author":"A Piga","year":"2003","unstructured":"Piga A, Gaglioti C, Fogliacco E, Tricta F. Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. Haematologica. 2003;88:489\u201396.","journal-title":"Haematologica"},{"key":"366_CR22","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ajh.27010","volume":"98","author":"MS Elalfy","year":"2023","unstructured":"Elalfy MS, Hamdy M, Adly A, et al. Efficacy and safety of early-start deferiprone in infants and young children with transfusion-dependent beta thalassemia: evidence for iron shuttling to transferrin in a randomized, double-blind, placebo-controlled, clinical trial (START). Am J Hematol. 2023;98:1415\u201324.","journal-title":"Am J Hematol"},{"key":"366_CR23","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.3324\/haematol.2013.098202","volume":"99","author":"F Danjou","year":"2014","unstructured":"Danjou F, Cabantchik ZI, Origa R, et al. A decisional algorithm to start iron chelation in patients with beta thalassemia. Haematologica. 2014;99:e38-40.","journal-title":"Haematologica"},{"key":"366_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3324\/haematol.2009.014696","volume":"95","author":"MD Cappellini","year":"2010","unstructured":"Cappellini MD, Porter J, El-Beshlawy A, et al. EPIC Study Investigators. Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. Haematologica. 2010;95:557\u201366.","journal-title":"Haematologica"},{"key":"366_CR25","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/ajh.24479","volume":"91","author":"F Tricta","year":"2016","unstructured":"Tricta F, Uetrecht J, Galanello R, et al. Deferiprone-induced agranulocytosis: 20 years of clinical observations. Am J Hematol. 2016;91:1026\u201331.","journal-title":"Am J Hematol"},{"key":"366_CR26","unstructured":"Desferal (deferoxamine mesylate): prescribing information. East Hanover (NJ): Novartis; 2011. Accessed on March 31, 2026. Available from: https:\/\/www.novartis.com\/us-en\/sites\/novartis_us\/files\/desferal.pdf."},{"key":"366_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1179\/1465328110Y.0000000002","volume":"31","author":"J Chandra","year":"2011","unstructured":"Chandra J, Chaudhary H, Pemde H, Singh V, Dutta AK. Safety and efficacy of deferasirox in multitransfused Indian children with \u03b2-thalassaemia major. Ann Trop Paediatr. 2011;31:47\u201351.","journal-title":"Ann Trop Paediatr"},{"key":"366_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ajh.23386","volume":"88","author":"V Viprakasit","year":"2013","unstructured":"Viprakasit V, Nuchprayoon I, Chuansumrit A, Torcharus K, Pongtanakul B, Laothamatas J, et al. Deferiprone (GPO-L-ONE(\u00ae)) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand. Am J Hematol. 2013;88:251\u201360.","journal-title":"Am J Hematol"},{"key":"366_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ajh.21711","volume":"85","author":"M Balocco","year":"2010","unstructured":"Balocco M, Carrara P, Pinto V, Forni GL. Daily alternating deferasirox and deferiprone therapy for \u201chard-to-chelate\u201d beta-thalassemia major patients. Am J Hematol. 2010;85:460\u20131.","journal-title":"Am J Hematol"},{"key":"366_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29564","volume":"69","author":"V Gupta","year":"2022","unstructured":"Gupta V, Kumar I, Raj V, Aggarwal P, Agrawal V. Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion-dependent thalassemia: a randomized double-blind placebo-controlled trial. Pediatr Blood Cancer. 2022;69:e29564.","journal-title":"Pediatr Blood Cancer"},{"key":"366_CR31","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1182\/blood-2016-06-721183","volume":"128","author":"JL Fernandes","year":"2016","unstructured":"Fernandes JL, Loggetto SR, Verissimo MP, et al. A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major. Blood. 2016;128:1555\u201361.","journal-title":"Blood"},{"key":"366_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/bjh.17839","volume":"196","author":"FT Shah","year":"2022","unstructured":"Shah FT, Porter JB, Sadasivam N, et al. Guidelines for the Monitoring and Management of Iron Overload in Patients With Hemoglobinopathies and Rare Anaemias. Br J Haematol. 2022;196:336\u201350.","journal-title":"Br J Haematol"},{"key":"366_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/MPH.0000000000000307","volume":"37","author":"VN Tubman","year":"2015","unstructured":"Tubman VN, Fung EB, Vogiatzi M, et al. Thalassemia clinical research network. guidelines for the standard monitoring of patients with thalassemia: report of the thalassemia longitudinal cohort. J Pediatr Hematol Oncol. 2015;37:162\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"366_CR34","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","volume":"120","author":"P Kirk","year":"2009","unstructured":"Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120:1961\u20138.","journal-title":"Circulation"},{"key":"366_CR35","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221856","volume":"307","author":"SB Reeder","year":"2023","unstructured":"Reeder SB, Yokoo T, Fran\u00e7a M, et al. Quantification of liver iron overload with MRI: review and guidelines from the ESGAR and SAR. Radiology. 2023;307:e221856.","journal-title":"Radiology"},{"key":"366_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.15406\/htij.2022.10.00281","volume":"10","author":"M Vijayaran","year":"2022","unstructured":"Vijayaran M. Multicentric cross-sectional review of blood transfusion, iron chelation therapy, T2 * MRI, and hematopoietic stem cell transplantation practices in thalassemia major patients in North India. Hematol Transfus Int. 2022;10:49\u201355.","journal-title":"Hematol Transfus Int"},{"key":"366_CR37","unstructured":"Ministry of Health and Family Welfare, Government of India. National guidelines for diagnosis and management of viral hepatitis. New Delhi: MoHFW; 2018. Accessed on April 2, 2026. Available from: https:\/\/nvhcp.mohfw.gov.in\/common_libs\/diagnosis-management-viral-hepatitis.pdf."},{"key":"366_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/ajts.AJTS_73_17","volume":"12","author":"KK Bhattacharyya","year":"2018","unstructured":"Bhattacharyya KK, Biswas A, Gupta D, Sadhukhan PC. Experience of hepatitis C virus sero-prevalence and its genomic diversity among transfusion dependant thalassemia patients in a transfusion centre. Asian J Transfus Sci. 2018;12:112\u20136.","journal-title":"Asian J Transfus Sci"},{"key":"366_CR39","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.20546\/ijcmas.2018.705.367","volume":"7","author":"CC Surani","year":"2018","unstructured":"Surani CC, Shah RV, Sinha M. A study of prevalence of hepatitis B and hepatitis C infection in thalassemia patients in a tertiary care hospital, Jamnagar, Gujarat, India. Int J Curr Microbiol App Sci. 2018;7:3142\u20136.","journal-title":"Int J Curr Microbiol App Sci"},{"key":"366_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13312-021-2162-1","volume":"58","author":"S Gomber","year":"2021","unstructured":"Gomber S, Yadav R, Dewan P, Ramachandran VG, Puri AS. Requirement of a booster dose of hepatitis B vaccine in children with thalassemia after 5 years of primary vaccination: a prospective study. Indian Pediatr. 2021;58:237\u201340.","journal-title":"Indian Pediatr"},{"key":"366_CR41","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/cncr.30462","volume":"123","author":"HM Moukhadder","year":"2017","unstructured":"Moukhadder HM, Halawi R, Cappellini MD, Taher AT. Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: a comprehensive review. Cancer. 2017;123:751\u20138.","journal-title":"Cancer"},{"key":"366_CR42","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.3109\/03630260903347526","volume":"33","author":"JC Wood","year":"2009","unstructured":"Wood JC. Cardiac complications in thalassemia major. Hemoglobin. 2009;33:S81\u20136.","journal-title":"Hemoglobin"},{"key":"366_CR43","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00277-019-03618-w","volume":"98","author":"F Koohi","year":"2019","unstructured":"Koohi F, Kazemi T, Mini-Moghaddam E. Cardiac complications and iron overload in \u03b2 thalassemia major patients- a systematic review and meta-analysis. Ann Hematol. 2019;98:1323\u201331.","journal-title":"Ann Hematol"},{"key":"366_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/ejhf.708","volume":"19","author":"D Farmakis","year":"2017","unstructured":"Farmakis D, Triposkiadis F, Lekakis J, Parissis J. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management. Eur J Heart Fail. 2017;19:479\u201389.","journal-title":"Eur J Heart Fail"},{"key":"366_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","volume":"128","author":"DJ Pennel","year":"2013","unstructured":"Pennel DJ, Udelson JE, Arai AE, et al. Cardiovascular Function and Treatment in \u03b2-Thalassemia Major\u2013A Consensus Statement From American Heart Association. Circulation. 2013;128:281\u2013330.","journal-title":"Circulation"},{"key":"366_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/2230-8210.107808","volume":"17","author":"V De Sanctis","year":"2013","unstructured":"De Sanctis V, Soliman AT, Elsedfy H, et al. Growth and endocrine disorders in thalassemia: the International Network on Endocrine Complications in Thalassemia (I-CET) position statement and guidelines. Indian J Endocrinol Metab. 2013;17:8\u201318.","journal-title":"Indian J Endocrinol Metab"},{"issue":"Suppl 2","key":"366_CR47","first-page":"271","volume":"8","author":"N Skordis","year":"2011","unstructured":"Skordis N, Kyriakou A. The multifactorial origin of growth failure in thalassaemia. Pediatr Endocrinol Rev. 2011;8(Suppl 2):271\u20137.","journal-title":"Pediatr Endocrinol Rev"},{"key":"366_CR48","volume":"1","author":"A Kyriakou","year":"2009","unstructured":"Kyriakou A, Skordis N. Thalassaemia and aberrations of growth and puberty. Mediterr J Hematol Infect Dis. 2009;1:e2009003.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"366_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1586\/17474086.2016.1136209","volume":"9","author":"V De Sanctis","year":"2016","unstructured":"De Sanctis V, Soliman AT, Elsedfy H, et al. Diabetes and glucose metabolism in thalassemia major: an update. Expert Rev Hematol. 2016;9:401\u20138.","journal-title":"Expert Rev Hematol"},{"key":"366_CR50","first-page":"435","volume":"88","author":"V De Sanctis","year":"2018","unstructured":"De Sanctis V, Soliman AT, Canatan D, et al. An ICET- A survey on hypoparathyroidism in patients with thalassaemia major and intermedia: A preliminary report. Acta Biomed. 2018;88:435\u201344.","journal-title":"Acta Biomed"},{"key":"366_CR51","first-page":"1","volume":"93","author":"MP Yavropoulou","year":"2022","unstructured":"Yavropoulou MP, Anastasilakis AD, Tzoulis P, et al. Approach to the management of \u03b2 thalassemia major associated osteoporosis-a long-standing relationship revisited. Acta Biomed. 2022;93:1\u201313.","journal-title":"Acta Biomed"},{"key":"366_CR52","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/diagnostics12081921","volume":"12","author":"M Carsote","year":"2022","unstructured":"Carsote M, Vasiliu C, Trandafir AI, et al. New entity-Thalassemic endocrine disease: Major beta-thalassemia and endocrine involvement. Diagnostics (Basel). 2022;12:1921.","journal-title":"Diagnostics (Basel)"},{"key":"366_CR53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/09723757.2003.11885858","volume":"3","author":"A Saxena","year":"2003","unstructured":"Saxena A. Growth retardation in thalassemia major patients. Int J Hum Genet. 2003;3:237\u201346.","journal-title":"Int J Hum Genet"},{"key":"366_CR54","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3324\/haematol.2020.252726","volume":"106","author":"ST Singer","year":"2021","unstructured":"Singer ST, Fischer R, Allen I, et al. Pituitary iron and factors predictive of fertility status in transfusion dependent thalassemia. Haematologica. 2021;106:1740\u20134.","journal-title":"Haematologica"},{"key":"366_CR55","volume-title":"Pediatric and adolescent oncofertility","author":"ST Singer","year":"2017","unstructured":"Singer ST. Fertility issues in transfusion dependent thalassemia patients: pathophysiology, assessment, management. In: Woodruff T, Gosiengfiao Y, editors. Pediatric and adolescent oncofertility. Switzerland: Springer; 2017."},{"key":"366_CR56","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/er.2015-1105","volume":"37","author":"P Wong","year":"2016","unstructured":"Wong P, Fuller PJ, Gillespie MT, Milat F. Bone disease in thalassemia: a molecular and clinical overview. Endocr Rev. 2016;37:320\u201346.","journal-title":"Endocr Rev"},{"key":"366_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115730","volume":"143","author":"N Shah","year":"2021","unstructured":"Shah N, Khadilkar A, Ekbote V, et al. DXA and pQCT derived parameters in Indian children with beta thalassemia major - A case controlled study. Bone. 2021;143:115730.","journal-title":"Bone"},{"key":"366_CR58","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","volume":"2017","author":"AT Taher","year":"2017","unstructured":"Taher AT, Saliba AN. Iron overload in thalassemia: different organs at different rates. Hematology Am Soc Hematol Educ Program. 2017;2017:265\u201371.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"366_CR59","volume":"5","author":"A Bhardwaj","year":"2023","unstructured":"Bhardwaj A, Swe KMM, Sinha NK. Treatment for osteoporosis in people with beta-thalassaemia. Cochrane Database Syst Rev. 2023;5:CD010429.","journal-title":"Cochrane Database Syst Rev"},{"key":"366_CR60","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.hoc.2014.08.009","volume":"28","author":"V Mathews","year":"2014","unstructured":"Mathews V, Srivastava A, Chandy M. Allogeneic stem cell transplantation for thalassemia major. Hematol Oncol Clin North Am. 2014;28:1187\u2013200.","journal-title":"Hematol Oncol Clin North Am"},{"key":"366_CR61","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.bbmt.2007.05.004","volume":"13","author":"V Mathews","year":"2007","unstructured":"Mathews V, George B, Deotare U, et al. A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007;13:889\u201394.","journal-title":"Biol Blood Marrow Transplant"},{"key":"366_CR62","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1182\/bloodadvances.2019000291","volume":"3","author":"C Li","year":"2019","unstructured":"Li C, Mathews V, Kim S, et al. Related and unrelated donor transplantation for \u03b2-thalassemia major: results of an international survey. Blood Adv. 2019;3:2562\u201370.","journal-title":"Blood Adv"},{"key":"366_CR63","doi-asserted-by":"crossref","unstructured":"Angelucci E, Matthes-Martin S, Baronciani D, EBMT Inborn Error and EBMT Paediatric Working Parties, et al. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: Indications and management recommendations from an international expert panel. Haematologica. 2014;99:811\u201320.","DOI":"10.3324\/haematol.2013.099747"},{"key":"366_CR64","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.bbmt.2014.07.016","volume":"20","author":"U Anurathapan","year":"2014","unstructured":"Anurathapan U, Pakakasama S, Mekjaruskul P, et al. Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification. Biol Blood Marrow Transplant. 2014;20:2066\u201371.","journal-title":"Biol Blood Marrow Transplant"},{"key":"366_CR65","unstructured":"Indian Council of Medical Research. National Guidelines for Hematopoietic Cell Transplantation. New Delhi: ICMR; 2021. Accessed on April 2, 2026. Available from: https:\/\/www.icmr.gov.in\/icmrobject\/custom_data\/pdf\/resource-guidelines\/Nat_Guide_HCT.pdf."},{"key":"366_CR66","doi-asserted-by":"publisher","first-page":"271.e1","DOI":"10.1016\/j.jtct.2023.01.020","volume":"29","author":"A Cattoni","year":"2023","unstructured":"Cattoni A, Capitoli G, Casagranda S, et al. Iron overload following hematopoietic stem cell transplantation: prevalence, severity, and management in children and adolescents with malignant and nonmalignant diseases. Transplant Cell Ther. 2023;29:271.e1-271.e12.","journal-title":"Transplant Cell Ther"},{"key":"366_CR67","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00277-021-04501-3","volume":"100","author":"D Bhurani","year":"2021","unstructured":"Bhurani D, Kapoor J, Yadav N, et al. Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients. Ann Hematol. 2021;100:1417\u201327.","journal-title":"Ann Hematol"},{"key":"366_CR68","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1111\/bjh.16272","volume":"188","author":"S Shah","year":"2020","unstructured":"Shah S, Sheth R, Shah K, Patel K. Safety and effectiveness of thalidomide and hydroxyurea combination in \u03b2-thalassemia intermedia and major: a retrospective pilot study. Br J Haematol. 2020;188:e18\u201321.","journal-title":"Br J Haematol"},{"key":"366_CR69","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s13312-021-2254-y","volume":"58","author":"J Chandra","year":"2021","unstructured":"Chandra J, Parakh N, Sidharth, et al. Efficacy and safety of thalidomide in patients with transfusion-dependent thalassemia. Indian Pediatr. 2021;58:611\u20136.","journal-title":"Indian Pediatr"},{"key":"366_CR70","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","volume":"382","author":"MD Cappellini","year":"2020","unstructured":"Cappellini MD, Viprakasit V, Taher AT, et al. BELIEVE Investigators. A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia. N Engl J Med. 2020;382:1219\u201331.","journal-title":"N Engl J Med"},{"key":"366_CR71","unstructured":"Taher AT, Cappellini MD, Kattamis A, et al; BEYOND Investigators. Luspatercept for the treatment of anaemia in non-transfusion-dependent \u03b2-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial. Lancet Haematol. 2022;9:e733-e744."},{"key":"366_CR72","doi-asserted-by":"crossref","unstructured":"Taher AT, Al-Samkari H, Aydinok Y, et al; ENERGIZE investigators. Mitapivat in adults with non-transfusion-dependent \u03b1-thalassaemia or \u03b2-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial. Lancet. 2025;406:33\u201342.","DOI":"10.1016\/S0140-6736(25)00635-X"},{"issue":"Suppl","key":"366_CR73","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1097\/01.HS9.0000851756.51961.79","volume":"6","author":"A Lal","year":"2022","unstructured":"Lal A, Brown RC, Coates T, et al. PB2232: Trial in progress: A phase 2, open-label study evaluating the safety and efficacy of the erythrocyte pyruvate kinase activator etavopivat in patients with thalassemia or sickle cell disease. Hemasphere. 2022;6(Suppl):2102\u20133.","journal-title":"Hemasphere"},{"key":"366_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.730873","volume":"12","author":"P Rattananon","year":"2021","unstructured":"Rattananon P, Anurathapan U, Bhuchar K, Hongeng S. The future of gene therapy for transfusion-dependent beta-thalassemia: the power of the lentiviral vector for genetically modified hematopoietic stem cells. Front Pharmacol. 2021;12:730873.","journal-title":"Front Pharmacol"},{"key":"366_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmac087","volume":"68","author":"T Agrawal","year":"2022","unstructured":"Agrawal T, Dewan P, Gomber S, Agarwal R, Sharma S, Kotru M. Optimum dose of oral folic acid supplementation in transfusion-dependent thalassemia: A randomized controlled trial. J Trop Pediatr. 2022;68:fmac087.","journal-title":"J Trop Pediatr"},{"key":"366_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1587738","volume":"13","author":"RK Agarwal","year":"2025","unstructured":"Agarwal RK, Periyavan S, Trivedi D, et al. Measuring success of targeted screening and prevention for hemoglobinopathies. Front Public Health. 2025;13:1587738.","journal-title":"Front Public Health"},{"key":"366_CR77","first-page":"61","volume":"20","author":"S Thakur","year":"2019","unstructured":"Thakur S, Singh S. Genetic counseling to prevent thalassemia and hemoglobinopathy in the Indian population. Perinatology. 2019;20:61\u20136.","journal-title":"Perinatology"},{"key":"366_CR78","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-026-06099-8","author":"R Das","year":"2026","unstructured":"Das R, Nadkarni A, Kohli S, et al. Experience of prenatal diagnosis for \u03b2-thalassemia and major hemoglobinopathies in the last decade from seven tertiary-care referral centers in India. Indian J Pediatr. 2026. https:\/\/doi.org\/10.1007\/s12098-026-06099-8.","journal-title":"Indian J Pediatr"},{"key":"366_CR79","unstructured":"Ministry of Health and Family Welfare, Government of India. Prevention and Control of Hemoglobinopathies in India: Thalassemias, Sickle Cell Disease and Other Variant Hemoglobins. New Delhi: National Health Mission; 2016. Accessed on Mar 31, 2026. Available from: https:\/\/nhm.gov.in\/images\/pdf\/programmes\/RBSK\/Resource_Documents\/Guidelines_on_Hemoglobinopathies_in%20India.pdf."},{"key":"366_CR80","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/vox.70157","volume":"121","author":"N Radhakrishnan","year":"2026","unstructured":"Radhakrishnan N, Chandra J, Manglani M, Trehan A, Arora JS, Tuli S. Assessment of services for diagnosis, management and prevention of thalassaemia in India: the way forward. Vox Sang. 2026;121:289\u201397.","journal-title":"Vox Sang"},{"key":"366_CR81","unstructured":"Department of Empowerment of Persons with Disabilities. About persons with disability (UDID\/Swavlamban Card). New Delhi: Ministry of Social Justice and Empowerment, Government of India. Accessed on April 2, 2026. Available from: https:\/\/swavlambancard.gov.in\/about-persons-with-disability."},{"key":"366_CR82","unstructured":"Coal India Limited. Thalassemia Bal Sewa Yojana (TBSY)\u2013About Us [Internet]. Kolkata: Coal India Ltd. Accessed on Mar 31, 2026. Available from: https:\/\/www.coalindia.in\/tbsy\/about-us\/."},{"key":"366_CR83","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13312-024-3137-9","volume":"61","author":"J Chandra","year":"2024","unstructured":"Chandra J, Manglani M, Aneja S, et al. The Indian Academy of Pediatrics and Directorate General of Health Services, Government of India White Paper on Transition of Care for Youth with Special Health Care Needs. Indian Pediatr. 2024;61:475\u201381.","journal-title":"Indian Pediatr"},{"key":"366_CR84","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ejh.13410","volume":"105","author":"D Farmakis","year":"2020","unstructured":"Farmakis D, Giakoumis A, Angastiniotis M, Eleftheriou A. The changing epidemiology of the ageing thalassaemia populations: a position statement of the Thalassaemia International Federation. Eur J Haematol. 2020;105:16\u201323.","journal-title":"Eur J Haematol"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-026-00366-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-026-00366-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-026-00366-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:02:17Z","timestamp":1787554937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-026-00366-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["366"],"URL":"https:\/\/doi.org\/10.1007\/s13312-026-00366-9","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}